CRONOS GROUP INC. Foreign Currency Transaction Gain (Loss), Unrealized
CRONOS GROUP INC. (CRON) reported Foreign Currency Transaction Gain (Loss), Unrealized of $20.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-08-06
- CRONOS GROUP INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-06-30 was $20.22M.
- CRONOS GROUP INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2026-03-31 was $13.70M, a 765.38% increase year-over-year.
- CRONOS GROUP INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-12-31 was -$10.42M, a 122.90% decline year-over-year.
- CRONOS GROUP INC. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-30 was $19.79M.
- CRONOS GROUP INC. foreign currency transaction gain (loss), unrealized for fiscal 2025 was -$28.59M, a 149.41% decline from fiscal 2024.
- CRONOS GROUP INC. foreign currency transaction gain (loss), unrealized for fiscal 2024 was $57.86M.
- CRONOS GROUP INC. foreign currency transaction gain (loss), unrealized for fiscal 2023 was -$7.32M.
- CRONOS GROUP INC. foreign currency transaction gain (loss), unrealized for fiscal 2022 was -$2.29M.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.22M 10-Q · filed 2026-08-06 | $33.92M 10-Q · filed 2026-08-06 | $23.50M derived: sum of 3 quarters · filed 2026-08-06 | $43.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $13.70M 10-Q · filed 2026-05-11 | $3.28M derived: sum of 2 quarters · filed 2026-05-11 | $23.07M derived: sum of 3 quarters · filed 2026-05-11 | -$16.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$10.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $9.37M derived: sum of 2 quarters · filed 2026-02-26 | -$30.17M derived: sum of 3 quarters · filed 2026-08-06 | -$28.59M 10-K · filed 2026-02-26 |
| 2025-09-30 | $19.79M 10-Q · filed 2025-11-06 | -$19.75M derived: sum of 2 quarters · filed 2026-08-06 | -$18.17M 10-Q · filed 2025-11-06 | $27.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$39.54M 10-Q · filed 2026-08-06 | -$37.95M 10-Q · filed 2026-08-06 | $7.53M derived: sum of 3 quarters · filed 2026-08-06 | $102.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.58M 10-Q · filed 2026-05-11 | $47.07M derived: sum of 2 quarters · filed 2026-05-11 | $39.64M derived: sum of 3 quarters · filed 2026-05-11 | $46.18M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $45.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.06M derived: sum of 2 quarters · filed 2026-02-26 | $44.60M derived: sum of 3 quarters · filed 2026-02-26 | $57.86M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$7.43M 10-Q · filed 2025-11-06 | -$889.00K derived: sum of 2 quarters · filed 2025-11-06 | $12.37M 10-Q · filed 2025-11-06 | $1.05M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $6.54M 10-Q · filed 2025-08-07 | $19.80M 10-Q · filed 2025-08-07 | $8.48M derived: sum of 3 quarters · filed 2026-02-26 | $17.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $13.26M 10-Q · filed 2025-05-08 | $1.94M derived: sum of 2 quarters · filed 2026-02-26 | $10.75M derived: sum of 3 quarters · filed 2026-02-26 | $7.58M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$11.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.51M derived: sum of 2 quarters · filed 2026-02-26 | -$5.68M derived: sum of 3 quarters · filed 2026-02-26 | -$7.32M 10-K · filed 2026-02-26 |
| 2023-09-30 | $8.82M 10-Q · filed 2024-11-12 | $5.64M derived: sum of 2 quarters · filed 2024-11-12 | $4.00M 10-Q · filed 2024-11-12 | $4.05M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$3.17M 10-Q · filed 2024-08-08 | -$4.82M 10-Q · filed 2024-08-08 | -$4.77M derived: sum of 3 quarters · filed 2025-02-27 | -$2.38M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$1.64M 10-Q · filed 2024-05-09 | -$1.59M derived: sum of 2 quarters · filed 2025-02-27 | $795.00K derived: sum of 3 quarters · filed 2025-02-27 | -$2.06M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.44M derived: sum of 2 quarters · filed 2025-02-27 | -$414.00K derived: sum of 3 quarters · filed 2025-02-27 | -$2.29M 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.39M 10-Q · filed 2023-11-08 | -$465.00K derived: sum of 2 quarters · filed 2023-11-08 | -$2.34M 10-Q · filed 2023-11-08 | -$2.34M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$2.85M 10-Q · filed 2023-08-08 | -$4.72M 10-Q · filed 2023-08-08 | -$4.72M derived: sum of 3 quarters · filed 2024-02-29 | -$4.72M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$1.87M 10-Q · filed 2023-05-09 | -$1.87M derived: sum of 2 quarters · filed 2024-02-29 | -$1.87M derived: sum of 3 quarters · filed 2024-02-29 | -$1.87M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | -$3.02M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | -$3.02M derived: sum of 3 quarters · filed 2023-02-28 | -$1.10M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | -$3.02M derived: sum of 2 quarters · filed 2023-02-28 | -$1.10M derived: sum of 3 quarters · filed 2023-02-28 | -$412.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$1.10M derived: sum of 2 quarters · filed 2023-02-28 | -$412.00K derived: sum of 3 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.61M derived: sum of 2 quarters · filed 2020-11-05 | $3.02M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $685.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.10M 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $412.00K 10-Q · filed 2020-05-08 | |||
| 2019-09-30 | -$623.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$756.00K derived: sum of 2 quarters · filed 2020-11-05 | -$807.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$184.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$51.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |